Skip to main content

and
  1. Article

    Open Access

    Alternative boronic acids in the detection of Mycolactone A/B using the thin layer chromatography (f-TLC) method for diagnosis of Buruli ulcer

    Mycobacterium ulcerans is the causative agent of Buruli ulcer. The pathology of M. ulcerans disease has been attributed to the secretion of a potent macrolide cytotoxin known as mycolactone which plays an importa...

    Gideon A. Akolgo, Benjamin M. Partridge, Timothy D. Craggs in BMC Infectious Diseases (2023)

  2. No Access

    Chapter

    Versatile Structurally Diverse Natural Products and Their Semisynthetic Analogs as Potential Antileishmanial Drugs

    Mortalities associated with leishmaniasis are skyrocketing at an alarming rate. Lack of vaccine for leishmaniasis treatment is making the fight against the disease an arduous one. Interestingly, apart from the...

    Patrick O. Sakyi, Richard K. Amewu in Natural Product Based Drug Discovery Again… (2023)

  3. No Access

    Article

    Unravelling the myth surrounding sterol biosynthesis as plausible target for drug design against leishmaniasis

    The mortality rate of leishmaniasis is increasing at an alarming rate and is currently second to malaria amongst the other neglected tropical diseases. Unfortunately, many governments and key stakeholders are ...

    Patrick O. Sakyi, Richard K. Amewu, Robert N. O. A. Devine in Journal of Parasitic Diseases (2021)

  4. Article

    Open Access

    The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade

    Despite advancements in the areas of omics and chemoinformatics, potent novel biotherapeutic molecules with new modes of actions are needed for leishmaniasis. The socioeconomic burden of leishmaniasis remains ...

    Patrick O. Sakyi, Richard K. Amewu in Natural Products and Bioprospecting (2021)

  5. Article

    Open Access

    A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance

    K13 gene mutations are a primary marker of artemisinin resistance in Plasmodium falciparum malaria that threatens the long-term clinical utility of artemisinin-based combination therapies, the cornerstone of mode...

    Paul M. O’Neill, Richard K. Amewu, Susan A. Charman, Sunil Sabbani in Nature Communications (2017)